Have a feature idea you'd love to see implemented? Let us know!

QURE uniQure NV

Price (delayed)

$5.735

Market cap

$279.28M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.93

Enterprise value

$525.84M

uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline ...

Highlights
The gross profit has soared by 183% from the previous quarter but it has plunged by 99% YoY
The gross margin has soared by 157% since the previous quarter but it has dropped by 95% year-on-year
The equity has shrunk by 73% YoY and by 34% QoQ
The quick ratio is down by 38% year-on-year and by 26% since the previous quarter

Key stats

What are the main financial stats of QURE
Market
Shares outstanding
48.7M
Market cap
$279.28M
Enterprise value
$525.84M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.87
Price to sales (P/S)
10.06
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.98
Earnings
Revenue
$27.71M
EBIT
-$216.72M
EBITDA
-$204.63M
Free cash flow
-$110.6M
Per share
EPS
-$5.93
Free cash flow per share
-$2.27
Book value per share
$2
Revenue per share
$0.57
TBVPS
$13.35
Balance sheet
Total assets
$730.85M
Total liabilities
$633.74M
Debt
$534.44M
Equity
$97.11M
Working capital
$511.5M
Liquidity
Debt to equity
5.5
Current ratio
7.36
Quick ratio
6.61
Net debt/EBITDA
-1.2
Margins
EBITDA margin
-738.6%
Gross margin
4.3%
Net margin
-1,027.5%
Operating margin
-872.9%
Efficiency
Return on assets
-35.5%
Return on equity
-158.1%
Return on invested capital
-23.4%
Return on capital employed
-33.3%
Return on sales
-782.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

QURE stock price

How has the uniQure stock price performed over time
Intraday
3.15%
1 week
-10.67%
1 month
1.5%
1 year
-6.29%
YTD
-15.29%
QTD
16.33%

Financial performance

How have uniQure's revenue and profit performed over time
Revenue
$27.71M
Gross profit
$1.18M
Operating income
-$241.86M
Net income
-$284.69M
Gross margin
4.3%
Net margin
-1,027.5%
The gross profit has soared by 183% from the previous quarter but it has plunged by 99% YoY
The gross margin has soared by 157% since the previous quarter but it has dropped by 95% year-on-year
The company's revenue has shrunk by 75% YoY but it rose by 46% QoQ
The net income has dropped by 52% year-on-year but it rose by 4.1% since the previous quarter

Growth

What is uniQure's growth rate over time

Valuation

What is uniQure stock price valuation
P/E
N/A
P/B
2.87
P/S
10.06
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
18.98
The company's EPS has shrunk by 51% YoY but it rose by 4.5% QoQ
The equity has shrunk by 73% YoY and by 34% QoQ
QURE's P/B is 64% above its last 4 quarters average of 1.7 but 23% below its 5-year quarterly average of 3.6
The P/S is 88% lower than the 5-year quarterly average of 82.4 and 12% lower than the last 4 quarters average of 11.1
The company's revenue has shrunk by 75% YoY but it rose by 46% QoQ

Efficiency

How efficient is uniQure business performance
The ROA has contracted by 39% YoY and by 2% from the previous quarter
The company's return on sales rose by 38% QoQ
The return on invested capital has increased by 35% year-on-year and by 10% since the previous quarter
The return on equity has declined by 30% since the previous quarter

Dividends

What is QURE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for QURE.

Financial health

How did uniQure financials performed over time
QURE's total assets is 15% greater than its total liabilities
The quick ratio is down by 38% year-on-year and by 26% since the previous quarter
The current ratio has contracted by 34% YoY and by 22% from the previous quarter
The equity has shrunk by 73% YoY and by 34% QoQ
The debt to equity is up by 49% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.